A detailed history of Wolverine Asset Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Wolverine Asset Management LLC holds 500 shares of ABBV stock, worth $91,540. This represents 0.0% of its overall portfolio holdings.

Number of Shares
500
Previous 2,400 79.17%
Holding current value
$91,540
Previous $411,000 76.16%
% of portfolio
0.0%
Previous 0.01%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

BUY
$154.79 - $180.76 $125,070 - $146,054
808 New
808 $138,000
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $5.9 Million - $6.83 Million
-44,172 Reduced 76.48%
13,583 $2.02 Million
Q2 2023

Aug 07, 2023

BUY
$132.51 - $164.9 $5.39 Million - $6.71 Million
40,712 Added 238.88%
57,755 $7.78 Million
Q1 2023

May 08, 2023

BUY
$144.61 - $166.54 $2.46 Million - $2.84 Million
17,043 New
17,043 $2.72 Million
Q2 2021

Aug 13, 2021

SELL
$105.21 - $117.21 $83,326 - $92,830
-792 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$102.3 - $112.62 $81,021 - $89,195
792 New
792 $85,000
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $3.79 Million - $4.49 Million
-42,269 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$92.01 - $123.21 $208,770 - $279,563
2,269 Added 5.67%
42,269 $4 Million
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $1.88 Million - $2.06 Million
-20,988 Reduced 34.41%
40,000 $3.87 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $3.55 Million - $4.53 Million
50,787 Added 497.86%
60,988 $5.42 Million
Q2 2017

Aug 14, 2017

BUY
N/A
10,201
10,201 $739,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $324B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Wolverine Asset Management LLC Portfolio

Follow Wolverine Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Asset Management LLC with notifications on news.